https://www.filament.health https://www.filament.health/about-us https://www.filament.health/drug-access https://www.filament.health/drug-development https://www.filament.health/investors https://www.filament.health/news https://www.filament.health/privacy-policy https://www.filament.health/technology https://www.filament.health/why-natural https://www.filament.health/spac-combination-faq https://www.filament.health/social-responsibility https://www.filament.health/news/2023-psychedelic-industry-outlook https://www.filament.health/news/3-microdosing-clinical-trials-to-keep-an-eye-on https://www.filament.health/news/a-canadian-psychedelic-drug-company-has-created-medical-grade-ayahuasca https://www.filament.health/news/a-conversation-with-dr-valorie-masuda-physician-and-psilocybin-access-advocate https://www.filament.health/news/a-gimmick-or-the-future-of-mental-health-psychedelic-therapy-in-the-metaverse https://www.filament.health/news/a-year-end-letter-from-ceo-ben-lightburn https://www.filament.health/news/all-about-psychedelic-assisted-psychotherapy https://www.filament.health/news/ayahuasca-pill-is-officially-here-filament-ceo-discusses-future-plans https://www.filament.health/news/beyond-capital-the-non-monetary-efforts-that-are-pushing-the-psychedelic-renaissance-forward https://www.filament.health/news/can-psychedelics-aid-canadas-mental-health-crisis-one-expert-says-yes https://www.filament.health/news/canadians-deserve-equitable-access-to-psychedelic-assisted-therapy https://www.filament.health/news/causes-or-cures-podcast-natural-vs-synthetic-psychedelics-does-it-matter https://www.filament.health/news/cocaine-plays-meet-the-companies-with-an-angle-on-hard-drugs https://www.filament.health/news/colorado-will-vote-on-legalizing-psychedelic-mushrooms-in-november https://www.filament.health/news/despite-newsom-veto-california-can-lead-on-psychedelics-policy https://www.filament.health/news/driving-disruption-ben-lightburn-of-filament-health-on-the-innovative-approaches-they-are-taking-to-disrupt-their-industries https://www.filament.health/news/drug-companies-join-medical-psychedelic-movement-but-without-the-high https://www.filament.health/news/effectiveness-of-psychedelics-on-alcohol-use-disorder-the-focus-of-u-of-c-study https://www.filament.health/news/end-of-year-letter-from-filament-ceo-ben-lightburn https://www.filament.health/news/extended-insight-webinar https://www.filament.health/news/fda-approved-study-to-investigate-therapeutic-potential-of-mushroom-derived-psilocin-and-psilocybin https://www.filament.health/news/filament-announces-c-10m-offering-and-filing-of-initial-listing-application https://www.filament.health/news/filament-announces-first-gmp-batch-of-pharmaceutical-grade-natural-psilocybin https://www.filament.health/news/filament-announces-shareholder-approval-of-amalgamation-and-closing-of-private-placement-financing https://www.filament.health/news/filament-begins-first-ever-fda-approved-clinical-trial-on-naturally-derived-psychedelic-drugs https://www.filament.health/news/filament-ceo-natural-psilocybin-is-the-logical-option-so-why-is-the-industry-stuck-on-synthetic https://www.filament.health/news/filament-gets-approval-for-phase-2-trial-of-psilocybin-drug-for-depression https://www.filament.health/news/filament-health-acquires-patent-for-extracting-and-standardizing-natural-psilocybin https://www.filament.health/news/filament-health-and-atma-journey-centers-announce-14-subjects-dosed-in-health-canada-approved-psilocybin-clinical-trial https://www.filament.health/news/filament-health-and-atma-journey-centers-announce-licensing-agreement https://www.filament.health/news/filament-health-and-cybin-therapeutics-announce-approval-for-phase-ii-clinical-trial-for-depression https://www.filament.health/news/filament-health-and-cybin-therapeutics-announce-licensing-agreement https://www.filament.health/news/filament-health-and-jaguar-health-joint-venture-magdalena-biosciences-completes-import-of-coca-leaf-from-peru https://www.filament.health/news/filament-health-and-jaguar-health-sign-letter-of-intent-to-develop-botanical-prescription-drugs-for-specific-mental-health-indications https://www.filament.health/news/filament-health-and-nasdaq-listed-spac-jupiter-acquisition-corp-announce-filing-of-sec-registration-statement https://www.filament.health/news/filament-health-and-nasdaq-listed-spac-jupiter-acquisition-corporation-announce-form-f-4-registration-statement-declared-effective-by-the-u-s-securities-and-exchange-commission-and-mailing-of-definitive-proxy-statement https://www.filament.health/news/filament-health-and-pharmala-biotech-announce-release-of-gmp-mdma-capsules https://www.filament.health/news/filament-health-and-psyence-announce-worldwide-licensing-agreement-of-psilocybin-capsule-for-palliative-care https://www.filament.health/news/filament-health-and-psyence-enter-into-exclusive-licensing-agreement-for-natural-psilocybin-products https://www.filament.health/news/filament-health-announces-adjournment-of-special-meeting https://www.filament.health/news/filament-health-announces-annual-general-meeting-voting-results https://www.filament.health/news/filament-health-announces-appointment-of-michael-messinger-to-its-board-of-directors https://www.filament.health/news/filament-health-announces-authorization-of-phase-2-clinical-trial-for-pex010-in-the-treatment-of-methamphetamine-use-disorder https://www.filament.health/news/filament-health-announces-authorization-of-phase-2-clinical-trial-studying-botanical-psilocybin-for-prolonged-grief-disorder https://www.filament.health/news/filament-health-announces-ceo-year-end-letter-and-change-to-board-of-directors https://www.filament.health/news/filament-health-announces-change-of-auditor https://www.filament.health/news/filament-health-announces-change-to-board-of-directors https://www.filament.health/news/filament-health-announces-clinical-trial-approval-in-partnership-with-psychiatric-centre-copenhagen https://www.filament.health/news/filament-health-announces-closing-of-2-500-080-private-placement https://www.filament.health/news/filament-health-announces-closing-of-warrant-exercise-note-conversion-and-concurrent-private-placement-of-common-shares https://www.filament.health/news/filament-health-announces-co-development-and-exclusive-licensing-agreement-with-entheotech-bioscience https://www.filament.health/news/filament-health-announces-dtc-eligibility-and-up-list-to-the-otcqb-exchange https://www.filament.health/news/filament-health-announces-eighth-patent-issuance https://www.filament.health/news/filament-health-announces-fda-approval-of-phase-ii-clinical-trial-studying-psilocybin-for-methamphetamine-use-disorder https://www.filament.health/news/filament-health-announces-fda-approval-of-two-clinical-trials-studying-its-botanical-psilocybin-drug-candidate-pex010 https://www.filament.health/news/filament-health-announces-fda-authorization-of-clinical-trial-with-first-ever-direct-psilocin-administration-and-first-ever-psychedelic-botanical-drug-candidates https://www.filament.health/news/filament-health-announces-fda-authorization-of-phase-2-clinical-trial-studying-pex010-the-companys-botanical-psilocybin-drug-candidate-in-opioid-use-disorder https://www.filament.health/news/filament-health-announces-fda-authorization-of-phase-2-clinical-trial-studying-psilocybin-for-alcohol-use-disorder-and-post-traumatic-stress-disorder-in-veterans-and-first-responders https://www.filament.health/news/filament-health-announces-fda-opening-of-investigational-new-drug-application-for-substance-use-disorders https://www.filament.health/news/filament-health-announces-first-dosing-in-groundbreaking-fda-approved-psilocin-clinical-trial https://www.filament.health/news/filament-health-announces-first-ever-compassionate-use-approval-for-psilocybin-in-the-european-union https://www.filament.health/news/filament-health-announces-first-ever-nagoya-protocol-compliant-shipment-of-iboga-from-gabon https://www.filament.health/news/filament-health-announces-first-quarter-2023-financial-results-and-operational-highlights https://www.filament.health/news/filament-health-announces-first-quarter-2023-financial-results-and-refiles-q1-2023-interim-financial-statements-and-md-a https://www.filament.health/news/filament-health-announces-first-quarter-2024-financial-results-and-operational-highlights https://www.filament.health/news/filament-health-announces-first-quarter-2025-financial-results-and-operational-highlights https://www.filament.health/news/filament-health-announces-fourth-patent-issuance https://www.filament.health/news/filament-health-announces-health-canada-approval-for-phase-ii-trial-administering-new-psilocybin-microdose-formulation https://www.filament.health/news/filament-health-announces-health-canada-authorization-for-phase-2-clinical-trial-studying-botanical-psilocybin-for-opioid-use-disorder https://www.filament.health/news/filament-health-announces-import-of-coca-leaf-from-peru-by-joint-venture-magdalena-biosciences https://www.filament.health/news/filament-health-announces-interim-results-from-phase-i-clinical-trial-at-the-university-of-california-san-francisco https://www.filament.health/news/filament-health-announces-issuance-of-common-shares-to-negev-capital-investments-limited-pursuant-to-advisory-agreement https://www.filament.health/news/filament-health-announces-major-intellectual-property-expansion https://www.filament.health/news/filament-health-announces-new-united-states-patent-issuances https://www.filament.health/news/filament-health-announces-participation-in-project-solace-2 https://www.filament.health/news/filament-health-announces-positive-data-from-phase-2-study-of-pex010-in-patients-with-alcohol-use-disorder https://www.filament.health/news/filament-health-announces-pre-ind-meeting-with-united-states-food-and-drug-administration https://www.filament.health/news/filament-health-announces-private-placement-and-intention-to-voluntarily-delist-from-cboe-canada https://www.filament.health/news/filament-health-announces-private-placement-of-units-and-convertible-debenture-units-of-up-to-2-500-000 https://www.filament.health/news/filament-health-announces-psilocybin-supply-agreement-with-the-centre-for-addiction-and-mental-health https://www.filament.health/news/filament-health-announces-q2-2021-financial-results https://www.filament.health/news/filament-health-announces-second-patent-issuance https://www.filament.health/news/filament-health-announces-second-psilocybin-supply-agreement-with-the-centre-for-addiction-and-mental-health https://www.filament.health/news/filament-health-announces-second-quarter-2022-financial-results-and-operational-highlights https://www.filament.health/news/filament-health-announces-second-quarter-2024-financial-results-and-operational-highlights https://www.filament.health/news/filament-health-announces-second-quarter-2025-financial-results-and-operational-highlights https://www.filament.health/news/filament-health-announces-shipment-of-botanical-psilocybin-to-the-university-of-wisconsin-madison https://www.filament.health/news/filament-health-announces-shipments-of-botanical-psilocybin-to-four-countries-for-clinical-investigation https://www.filament.health/news/filament-health-announces-signing-of-definitive-agreement-for-convertible-note-financing-closing-of-c-900-000-non-brokered-private-placement-financing-founder-led-note-offering-and-other-updates-related-to-proposed-business-combination https://www.filament.health/news/filament-health-announces-sixth-patent-issuance https://www.filament.health/news/filament-health-announces-spring-2023-event-and-media-appearances https://www.filament.health/news/filament-health-announces-termination-of-proposed-business-combination-with-jupiter-acquisition-corporation https://www.filament.health/news/filament-health-announces-termination-of-shareholder-meeting-and-engagement-of-donohoe-advisory-for-compliance-expertise https://www.filament.health/news/filament-health-announces-third-quarter-2022-financial-results-and-operational-highlights https://www.filament.health/news/filament-health-announces-third-quarter-2023-financial-results-and-operational-highlights https://www.filament.health/news/filament-health-announces-third-quarter-2024-financial-results-and-operational-highlights https://www.filament.health/news/filament-health-announces-third-quarter-2025-financial-results-and-operational-highlights https://www.filament.health/news/filament-health-announces-transition-from-otcqb-to-otc-pink-limited https://www.filament.health/news/filament-health-announces-two-phase-2-research-trials-in-partnership-with-university-college-london https://www.filament.health/news/filament-health-announces-upsizing-and-closing-of-2-500-000-non-brokered-private-placement-financing https://www.filament.health/news/filament-health-announces-voluntary-delisting-from-cboe-canada https://www.filament.health/news/filament-health-announces-warrant-exercise-and-note-conversion-by-negev-capital-and-concurrent-private-placement-of-common-shares-to-benjamin-lightburn-chief-executive-officer https://www.filament.health/news/filament-health-appoints-new-members-to-board-of-directors-and-advisory-council https://www.filament.health/news/filament-health-completes-the-first-export-of-botanical-psilocybin-to-australia https://www.filament.health/news/filament-health-completes-the-first-export-of-botanical-psilocybin-to-israel https://www.filament.health/news/filament-health-corp-announces-approval-for-listing-on-the-neo-exchange https://www.filament.health/news/filament-health-corp-announces-non-brokered-private-placement-unit-offering-led-by-negev-capital https://www.filament.health/news/filament-health-corp-announces-non-brokered-private-placement-unit-offering-of-up-to-c-2-000-000 https://www.filament.health/news/filament-health-corp-to-list-on-nasdaq-through-business-combination-with-jupiter-acquisition-corporation https://www.filament.health/news/filament-health-enters-exclusive-licensing-agreement-with-neolumina-bioscience-inc https://www.filament.health/news/filament-health-enters-into-exclusive-license-agreement-with-university-of-alabama-at-birmingham-for-data-from-a-clinical-trial-of-psilocybin-for-the-treatment-of-cocaine-use-disorder https://www.filament.health/news/filament-health-enters-licensing-agreement-with-reset-pharma https://www.filament.health/news/filament-health-files-20th-patent-application-including-three-international-pct-applications https://www.filament.health/news/filament-health-files-amended-pro-forma-financial-statements https://www.filament.health/news/filament-health-is-issued-patent-by-united-states-patent-and-trademark-office https://www.filament.health/news/filament-health-is-issued-second-patent-by-united-states-patent-and-trademark-office-and-reports-q1-results https://www.filament.health/news/filament-health-is-the-first-public-company-to-be-issued-a-patent-for-extraction-of-natural-psilocybin https://www.filament.health/news/filament-health-issued-third-patent-by-united-states-patent-and-trademark-office https://www.filament.health/news/filament-health-join-therapsil-in-worlds-largest-medical-psilocybin-access-and-data-project https://www.filament.health/news/filament-health-keeps-adding-patents-to-its-portfolio-just-received-its-fourth-2 https://www.filament.health/news/filament-health-keeps-adding-patents-to-its-portfolio-just-received-its-fourth-3 https://www.filament.health/news/filament-health-partners-with-trpr-psychedelic-research-program-at-ucsf-to-advance-first-drug-candidates-through-fda-phase-1-and-phase-2-clinical-trials https://www.filament.health/news/filament-health-reports-q4-and-year-end-2021-financial-results-and-operational-highlights https://www.filament.health/news/filament-health-reports-q4-and-year-end-2022-financial-results-and-operational-highlights https://www.filament.health/news/filament-health-reports-q4-and-year-end-2023-financial-results-and-operational-highlights https://www.filament.health/news/filament-health-reports-q4-and-year-end-2024-financial-results-and-operational-highlights https://www.filament.health/news/filament-health-reports-third-quarter-2021-financial-results-and-operational-highlights https://www.filament.health/news/filament-health-shares-to-commence-trading-on-the-otc-market https://www.filament.health/news/filament-health-signs-non-binding-term-sheet-for-convertible-note-in-connection-with-planned-business-combinatio https://www.filament.health/news/filament-health-subsidiary-psilo-scientific-announces-inclusion-in-health-canada-list-of-licensed-psilocybin-producers https://www.filament.health/news/filament-health-successfully-completes-industry-first-export-of-natural-gmp-psychedelics-to-the-united-states-through-its-wholly-owned-subsidiary-psilo-scientific-ltd https://www.filament.health/news/filament-health-to-host-virtual-investor-event https://www.filament.health/news/filament-health-to-host-virtual-investor-update https://www.filament.health/news/filament-health-to-host-virtual-investor-update-2 https://www.filament.health/news/filament-health-to-participate-in-key-psychedelics-conferences-in-december-2021 https://www.filament.health/news/filament-health-to-participate-in-prominent-psychedelic-investor-conferences-in-april-2022 https://www.filament.health/news/filament-health-to-participate-in-the-34th-annual-roth-conference https://www.filament.health/news/filament-health-to-supply-psilocybin-for-recipients-of-the-canadian-institutes-of-health-research-psilocybin-operating-grants https://www.filament.health/news/filament-leads-market-for-psychedelic-botanicals https://www.filament.health/news/filament-subsidiary-psilo-scientific-cultivates-20th-psychedelic-mushroom-variety-and-provides-propagation-update https://www.filament.health/news/first-patient-dosed-in-groundbreaking-psilocin-trial https://www.filament.health/news/germany-approves-eus-first-psilocybin-access-program https://www.filament.health/news/germany-becomes-first-european-country-to-approve-compassionate-use-of-psilocybin https://www.filament.health/news/germany-establishes-eus-first-psilocybin-compassionate-access-program https://www.filament.health/news/germany-pioneers-compassionate-psilocybin-access-for-treatment-resistant-depression-in-eu-first https://www.filament.health/news/germany-pioneers-compassionate-psilocybin-access-for-treatment-resistant-depression-in-eu-first-2 https://www.filament.health/news/germany-to-allow-use-of-psilocybin-for-drug-resistant-depression https://www.filament.health/news/growing-magic-mushrooms-chief-science-officer-at-b-c-lab-outlines-process-of-extracting-psilocybin https://www.filament.health/news/health-canada-must-reconsider-mans-bid-to-use-magic-mushrooms-for-cluster-headaches-federal-court-rules https://www.filament.health/news/highs-lows-of-psychedelics-research-wrapped-in-first-time-ucsf-trial https://www.filament.health/news/horizons-northwest-conference https://www.filament.health/news/in-crowded-field-of-psychedelic-startups-filament-ceo-makes-case-for-natural-drugs https://www.filament.health/news/innovative-trial-will-use-psilocybin-to-target-relapse-in-opioid-addiction https://www.filament.health/news/inside-the-vancouver-lab-where-scientists-legally-grow-magic-mushrooms https://www.filament.health/news/international-womens-day-2023 https://www.filament.health/news/is-there-more-to-magic-mushrooms-than-psilocybin https://www.filament.health/news/jaguar-filament-team-up-to-develop-botanical-drugs-for-mental-health-disorders https://www.filament.health/news/jaguar-health-and-filament-health-with-funding-from-one-small-planet-form-joint-venture-magdalena-biosciences-to-develop-botanical-pharmaceutical-drug-candidates-for-mental-health-illnesses https://www.filament.health/news/just-one-single-dose-of-magic-mushrooms-could-relieve-depression-for-5-years-researchers-find https://www.filament.health/news/labs-race-to-make-pharmaceutical-mdma-available-to-treat-mental-illness https://www.filament.health/news/magic-mushroom-industry-leaders-top-cultivation-companies https://www.filament.health/news/magic-mushrooms-could-lengthen-your-lifespan https://www.filament.health/news/marine-vet-touts-benefits-of-psychedelic-assisted-ptsd-drugs-as-fda-considers-mdma-approval https://www.filament.health/news/mission-matters-podcast-treating-people-suffering-from-mental-health-issues https://www.filament.health/news/mushrooms-potential-magic-in-quelling-alcohol-abuse-the-focus-of-u-of-c-researchers https://www.filament.health/news/natural-psychedelics-synthetics-untapped-alternative https://www.filament.health/news/natural-vs-synthetic-psilocybin-the-potency-problem https://www.filament.health/news/news-you-might-have-missed-april-19th-2022 https://www.filament.health/news/patents-in-psychedelics-explained https://www.filament.health/news/pharma-delics-ucsf-kicks-off-first-ever-trial-of-drug-naturally-derived-from-magic-mushrooms https://www.filament.health/news/psilocybin-psychedelic-compound-in-magic-mushrooms-shown-effective-for-alcohol-addiction https://www.filament.health/news/psilocybin-vs-psilocin https://www.filament.health/news/psych-symposium-panel https://www.filament.health/news/psyched-canadas-access-to-psychedelic-medicines-psilocybin-no-cognitive-side-effects-psilocybin-bill-washington https://www.filament.health/news/psyched-detroit-decriminalizes-psychedelics-compass-to-study-psilocybin-for-ptsd-filaments-gets-first-ever-fda-approval https://www.filament.health/news/psyched-elon-musk-praises-psychedelics-over-antidepressants-field-trip-to-split-in-two-colorado-mdma-bill-moves-forward https://www.filament.health/news/psychedelic-diaries-podcast https://www.filament.health/news/psychedelic-retreat-reports-183-spike-in-bookings-as-health-experts-cite-downside-of-unregulated-use https://www.filament.health/news/psychedelics-as-medicine-the-current-state-of-psychedelic-research https://www.filament.health/news/psychedelics-in-lieu-of-traditional-meds-for-mental-health https://www.filament.health/news/psychedelics-offer-a-new-mode-of-grief-therapy-but-theres-a-catch https://www.filament.health/news/psychedelics-q-a-with-ceo-ben-lightburn https://www.filament.health/news/psychedelics-substance-use-disorders-an-innovative-approach-to-a-growing-crisis https://www.filament.health/news/psychiatry-and-business-collaborate-european-psychedelics-trial-tackles-alcohol-addiction https://www.filament.health/news/psytechglobal https://www.filament.health/news/regulatory-approvals-place-filament-health-at-the-forefront-of-natural-psychedelic-research-and-manufacturing https://www.filament.health/news/safe-supply-vs-pharmaceutical-development-of-controlled-drugs-two-distinct-approaches https://www.filament.health/news/school-for-startups-podcast-legal-psychedelics https://www.filament.health/news/should-marijuana-extractors-consider-the-mushroom-market https://www.filament.health/news/shroom-boom https://www.filament.health/news/sourcing-ayahuasca-in-the-amazon-a-conversation-with-michael-coe https://www.filament.health/news/study-aims-to-determine-role-of-shrooms-in-battling-alcoholism https://www.filament.health/news/sxsw-2023-cannabis-and-psychedelics-panel https://www.filament.health/news/take-a-look-inside-the-b-c-lab-producing-magic-mushrooms https://www.filament.health/news/tdrs-top-5-psychedelic-developments-for-the-week-of-april-25 https://www.filament.health/news/the-bio-report-podcast-extracting-the-benefits-of-psychedelics https://www.filament.health/news/the-entourage-effect https://www.filament.health/news/the-fda-program-and-botanical-drug-pathway https://www.filament.health/news/the-fda-to-begin-studies-on-magic-mushrooms-a-first-for-the-agency https://www.filament.health/news/the-first-fda-approved-clinical-trial-of-psilocin-has-begun https://www.filament.health/news/the-future-is-trippy-the-fda-starts-its-first-ever-study-on-magic-mushrooms-and-psychedelics https://www.filament.health/news/the-missing-mushroom-psychedelic-science-and-the-future-of-psilocybin https://www.filament.health/news/the-next-steps-in-psychedelic-health-treatment https://www.filament.health/news/the-reasoning-behind-voluntarily-de-listing https://www.filament.health/news/these-patients-are-considering-maid-they-say-canada-has-made-it-harder-to-access-magic-mushrooms----a-treatment-giving-them-reason-to-live https://www.filament.health/news/thousands-of-moms-are-microdosing-with-mushrooms-to-ease-the-stress-of-parenting https://www.filament.health/news/totally-psychedelic-how-a-metro-vancouver-lab-is-reimagining-ayahuasca https://www.filament.health/news/tradertv https://www.filament.health/news/what-is-iboga-a-promising-yet-under-researched-psychoactive-plant https://www.filament.health/legal-documents/anti-bribery-and-anti-corruption-policy https://www.filament.health/legal-documents/anti-money-laundering-and-anti-terrorist-financing-policy https://www.filament.health/legal-documents/audit-committee-charter https://www.filament.health/legal-documents/board-of-directors-charter https://www.filament.health/legal-documents/charter-of-nominating-and-governance-committee https://www.filament.health/legal-documents/charter-of-the-compensation-committee https://www.filament.health/legal-documents/code-of-business-conduct-and-ethics-policy https://www.filament.health/legal-documents/disclosure-policy https://www.filament.health/legal-documents/diversity-of-board-policy https://www.filament.health/legal-documents/diversity-of-executive-officers-policy https://www.filament.health/legal-documents/insider-trading-policy https://www.filament.health/legal-documents/majority-voting-policy https://www.filament.health/legal-documents/privacy-policy https://www.filament.health/legal-documents/whistleblower-policy